|
|
12 quai Henri IV Paris, 75004 France phone:(+33)1 48 04 67 45 fax:(+33)1 48 04 67 23
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.crossject.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Crossject designs and develops innovative drug delivery solutions for pharmaceutical laboratories. |
 |
| Management |
| Chairman-Philippe Monnot, CEO, Business Dev.- Gérard Heinrich, Finance & Administration- Laurent Couston. |
| |
|
|
|
|
|
| Keywords |
| Drug Delivery, Needle-free injector, |
|
|
|
| Description |
|
Crossject owns 22 families of patent and one lead product: a needle-free, pre-filled single use injector, an advance in drug delivery that eliminates the traumatizing appearance of the traditional syringe and improves the comfort and safety of routine injection. |
 |
 |
|
|
|
|
|
|